Annett Linge

3.1k total citations
42 papers, 893 citations indexed

About

Annett Linge is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Annett Linge has authored 42 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Annett Linge's work include Head and Neck Cancer Studies (11 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Caveolin-1 and cellular processes (5 papers). Annett Linge is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Caveolin-1 and cellular processes (5 papers). Annett Linge collaborates with scholars based in Germany, Ireland and Denmark. Annett Linge's co-authors include Anna Dubrovska, Michaël Baumann, Mechthild Krause, Michael Kasper, Kathrin Barth, Steffen Löck, Martin Clynes, Paula Meleady, Michael Henry and Annemarie Larkin and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and Oncogene.

In The Last Decade

Annett Linge

40 papers receiving 884 citations

Peers

Annett Linge
Joshua C. Anderson United States
Alice Banh United States
Tiffany M. Phillips United States
Ke Sai China
Annett Linge
Citations per year, relative to Annett Linge Annett Linge (= 1×) peers Yawei Yuan

Countries citing papers authored by Annett Linge

Since Specialization
Citations

This map shows the geographic impact of Annett Linge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annett Linge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annett Linge more than expected).

Fields of papers citing papers by Annett Linge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annett Linge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annett Linge. The network helps show where Annett Linge may publish in the future.

Co-authorship network of co-authors of Annett Linge

This figure shows the co-authorship network connecting the top 25 collaborators of Annett Linge. A scholar is included among the top collaborators of Annett Linge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annett Linge. Annett Linge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukiyanchuk, Vasyl, Ielizaveta Gorodetska, Dragana Savic, et al.. (2025). Disruption of glutamine transport uncouples the NUPR1 stress-adaptation program and induces prostate cancer radiosensitivity. Cell Communication and Signaling. 23(1). 351–351. 1 indexed citations
2.
Richter, Susan, Steffen Löck, Annett Linge, et al.. (2024). Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer. Cancers. 16(4). 730–730. 6 indexed citations
3.
Linge, Annett, Ioana Plesca, Steffen Löck, et al.. (2024). Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients. Strahlentherapie und Onkologie. 200(7). 595–604.
4.
Plesca, Ioana, R Rothe, Steffen Löck, et al.. (2024). Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients. Frontiers in Immunology. 15. 1414298–1414298. 7 indexed citations
5.
Koi, Lydia, Annett Linge, Steffen Löck, et al.. (2023). Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts. Journal of Translational Medicine. 21(1). 576–576. 6 indexed citations
6.
Linge, Annett, Steffen Löck, Antje Dietrich, et al.. (2022). Plasticity within Aldehyde Dehydrogenase–Positive Cells Determines Prostate Cancer Radiosensitivity. Molecular Cancer Research. 20(5). 794–809. 11 indexed citations
7.
Zwanenburg, Alex, Annett Linge, Jan C. Peeken, et al.. (2022). Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models. Scientific Reports. 12(1). 10192–10192. 27 indexed citations
8.
Linge, Annett, Steffen Löck, Thilo Welsch, et al.. (2022). Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma. Clinical and Translational Radiation Oncology. 36. 106–112. 3 indexed citations
9.
Koi, Lydia, Michaël Baumann, Mechthild Krause, et al.. (2021). Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas. Cancers. 13(8). 1865–1865. 13 indexed citations
10.
Koi, Lydia, J. Müller, Robert Freudenberg, et al.. (2021). Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers. 13(22). 5595–5595. 2 indexed citations
12.
Seidlitz, Annekatrin, Bettina Beuthien‐Baumann, Steffen Löck, et al.. (2020). Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma. Clinical Cancer Research. 27(5). 1351–1360. 14 indexed citations
13.
Linge, Annett, Stefan E. Schmidt, Fabian Lohaus, et al.. (2019). Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy. Clinical and Translational Radiation Oncology. 16. 40–47. 14 indexed citations
14.
Liu, Qi, Lin Ma, Trevor J. Jones, et al.. (2018). Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining. Clinical Cancer Research. 24(23). 6001–6014. 72 indexed citations
15.
Linge, Annett, Ricarda Rauschenberg, S. Blum, et al.. (2018). Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma. Clinical and Translational Radiation Oncology. 15. 42–45. 6 indexed citations
16.
Koi, Lydia, Steffen Löck, Annett Linge, et al.. (2017). EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models. Radiotherapy and Oncology. 124(3). 496–503. 14 indexed citations
17.
Tawk, Bouchra, Christian Schwager, Gerhard Dyckhoff, et al.. (2015). Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma. Radiotherapy and Oncology. 118(2). 350–358. 42 indexed citations
18.
Linge, Annett, Paula Meleady, Michael Henry, et al.. (2010). Bleomycin treatment of A549 human lung cancer cells results in association of MGr1-Ag and caveolin-1 in lipid rafts. The International Journal of Biochemistry & Cell Biology. 43(1). 98–105. 11 indexed citations
19.
Barth, Kathrin, et al.. (2008). Characterization of the molecular interaction between caveolin-1 and the P2X receptors 4 and 7 in E10 mouse lung alveolar epithelial cells. The International Journal of Biochemistry & Cell Biology. 40(10). 2230–2239. 28 indexed citations
20.
Linge, Annett, et al.. (2007). Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells. The International Journal of Biochemistry & Cell Biology. 39(10). 1964–1974. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026